End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,010 KRW | -0.46% |
|
+1.64% | -11.68% |
Jan. 25 | Tae Kwang Corporation's Equity Buyback Plan Extended till January 26, 2025. | CI |
2023 | Tae Kwang Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 5.58 and 5.66 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.68% | 243M | - | ||
+20.02% | 9.14B | B+ | ||
+21.42% | 6.5B | - | C+ | |
+17.47% | 5.29B | C | ||
+17.49% | 4.73B | C+ | ||
+13.64% | 3.99B | A- | ||
+8.77% | 2.65B | D | ||
-3.40% | 2.46B | A- | ||
-42.58% | 2.18B | - | ||
-4.39% | 1.81B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A023160 Stock
- Ratings Tae Kwang Corporation